A Study of Abatacept in Patients With Active Crohn's Disease

• Status: Terminated
• Trial end date: 2009-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this clinical research study is to learn if abatacept can improve signs and symptoms of active Crohn's Disease in patients who have not had an adequate response to other therapies. The safety of this treatment will also be studied.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: Abatacept

Criteria

Inclusion Criteria:

• 18 years or older

• have had Crohn's Disease for at least 3 months

• moderate to severely active Crohn's Disease

• have had an inadequate response or intolerance to other Crohn's Disease treatments